Member Info for Soupdragon78

Bit of wishful thinking there. Any NFX and Kissei deal would not be part of any government level talks.

Just back to previous discussions about what NXP004 actually covers, I was just looking back at previous RNS' and forgot that the 002 also covered liver. So maybe they've developed 004 to cover that whilst 002 inhaled covers lungs?

From 28 Sept 2018
"Nuformix has previously demonstrated the potential for NXP002 to attenuate progression in established lung and liver fibrosis."

Nothing wrong with banking a profit scoobyrex, all the best.

Ah I see... you're a Lidl man.

£1.80 for a 500g bag in Sainsburys

With no news this morning, will be interesting to see how much strength this has.

Exactly Hale, if it had gone the other way he wouldn’t come on here to say he got it wrong.

Hopefully that 1.2m has cleared out and the overhang gone now. Its been worked all morning as they wouldn't quote to sell and size all day and now will give you a quote up to 600k.
Good that it hasn't knock the sp.

SuperJay!

SH4B, I made a couple of posts on this yesterday as it looks like the study was completed at the end of last month. Hopefully not too long before any news of the findings comes out, although it does say within 6 months.

Exactly Mozax, just shows the huge potential, we just need some decisive action from the board. It feels like their running through treacle at the moment.

Indeed goup. Thillai must have some role in strategy but not really the day to day development.

I do recall Aberdeenman using the word ‘commissioned’ though, which would be the ideal situation, rather than just the company looking at it in isolation.

Meanwhile, other companies are signing CRO deals to develop their nebuliser delivered Covid treatment.
NFX need to speed up their ‘review’ of academic research. Jo Holland surely isn’t doing everything?

aj242, oh yes you have, just under a different name.

?

Also the Chinese trial of using Tranilast re. Covid has now finished, so into the results phase there.

http://www.chictr.org.cn/showprojen.aspx?proj=49738

Why August or never?

Vistagen raised $12.5m in a placing yesterday for development of their CNS pipeline which includes NFX collaboration. So no worries from that side.

4.17p to buy, moving back up.

Hold for the real gains.

Lol. I bet it was the 92,386 trades that were hers. She previous bought at 3.9p and sold at 3.7p